Clay Siegall, PhD, is the President and CEO of Immunome, Inc., a position held since 2023. Previously, they served as President and CEO of Seagen from 1998 to 2022 and as President and CEO of MorphImmune in 2023. In addition, Siegall is currently the Chairman of Tourmaline Bio and a Board Member at Shattuck Labs. They are pursuing a Bachelor of Science in Zoology at the University of Maryland and a Doctor of Philosophy in Genetics at The George Washington University.
This person is not in the org chart
This person is not in any offices